Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: QIAGEN, LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-05-03 to 2026-05-31
Current total value of award: $175453.58
Description: RAPID, EVIDENCE-BASED INTERPRETATION TESTING FOR EVERY VARIANT, EVERY CANCER TYPE FOR EVERY PATIENT.